Valerio Therapeutics's total assets for Q2 2025 were €20.44M, an increase of 14.02% from the previous quarter. FR:ALVIO total liabilities were €28.89M for the fiscal quarter, a 10.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.